.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
UBS
Federal Trade Commission
Moodys
Daiichi Sankyo
Boehringer Ingelheim
Farmers Insurance
QuintilesIMS
Mallinckrodt
Cipla

Generated: December 15, 2017

DrugPatentWatch Database Preview

Alpharma Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for ALPHARMA PHARMS, and what generic alternatives to ALPHARMA PHARMS drugs are available?

ALPHARMA PHARMS has one approved drug.

There are nine US patents protecting ALPHARMA PHARMS drugs.

There are forty-seven patent family members on ALPHARMA PHARMS drugs in twenty-two countries.

Summary for Alpharma Pharms

International Patents:47
US Patents:9
Tradenames:1
Ingredients:1
NDAs:1
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Alpharma PharmsEMBEDAmorphine sulfate; naltrexone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL022321-002Aug 13, 2009RXYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
Alpharma PharmsEMBEDAmorphine sulfate; naltrexone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL022321-002Aug 13, 2009RXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Alpharma PharmsEMBEDAmorphine sulfate; naltrexone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL022321-003Aug 13, 2009RXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Alpharma PharmsEMBEDAmorphine sulfate; naltrexone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL022321-002Aug 13, 2009RXYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
Alpharma PharmsEMBEDAmorphine sulfate; naltrexone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL022321-006Aug 13, 2009RXYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
Alpharma PharmsEMBEDAmorphine sulfate; naltrexone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL022321-003Aug 13, 2009RXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Alpharma PharmsEMBEDAmorphine sulfate; naltrexone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL022321-005Aug 13, 2009RXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Alpharma PharmsEMBEDAmorphine sulfate; naltrexone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL022321-001Aug 13, 2009RXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Alpharma PharmsEMBEDAmorphine sulfate; naltrexone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL022321-001Aug 13, 2009RXYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
Alpharma PharmsEMBEDAmorphine sulfate; naltrexone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL022321-003Aug 13, 2009RXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Alpharma Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alpharma PharmsEMBEDAmorphine sulfate; naltrexone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL022321-002Aug 13, 2009► Subscribe► Subscribe
Alpharma PharmsEMBEDAmorphine sulfate; naltrexone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL022321-001Aug 13, 2009► Subscribe► Subscribe
Alpharma PharmsEMBEDAmorphine sulfate; naltrexone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL022321-003Aug 13, 2009► Subscribe► Subscribe
Alpharma PharmsEMBEDAmorphine sulfate; naltrexone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL022321-006Aug 13, 2009► Subscribe► Subscribe
Alpharma PharmsEMBEDAmorphine sulfate; naltrexone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL022321-005Aug 13, 2009► Subscribe► Subscribe
Alpharma PharmsEMBEDAmorphine sulfate; naltrexone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL022321-002Aug 13, 2009► Subscribe► Subscribe
Alpharma PharmsEMBEDAmorphine sulfate; naltrexone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL022321-001Aug 13, 2009► Subscribe► Subscribe
Alpharma PharmsEMBEDAmorphine sulfate; naltrexone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL022321-003Aug 13, 2009► Subscribe► Subscribe
Alpharma PharmsEMBEDAmorphine sulfate; naltrexone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL022321-004Aug 13, 2009► Subscribe► Subscribe
Alpharma PharmsEMBEDAmorphine sulfate; naltrexone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL022321-004Aug 13, 2009► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for ALPHARMA PHARMS drugs

Drugname Dosage Strength Tradename Submissiondate
morphine sulfate and naltrexone hydrochlorideExtended-release Capsules30 mg/1.2 mg, 50 mg/2 mg and 80 mg/3.2 mgEMBEDA5/28/2010
morphine sulfate and naltrexone hydrochlorideExtended-release Capsules60 mg/2.4 mgEMBEDA5/25/2010
morphine sulfate and naltrexone hydrochlorideExtended-release Capsules100 mg/4 mgEMBEDA5/3/2010

International Patent Family for Alpharma Pharms Drugs

Country Document Number Estimated Expiration
European Patent Office1551372► Subscribe
Australia2009251081► Subscribe
Australia2003270778► Subscribe
Denmark2484346► Subscribe
South Africa200810501► Subscribe
World Intellectual Property Organization (WIPO)2009079518► Subscribe
Denmark2719378► Subscribe
Cyprus1118077► Subscribe
European Patent Office2422773► Subscribe
Slovenia2034975► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Chinese Patent Office
Cipla
Medtronic
Fish and Richardson
Deloitte
Julphar
Boehringer Ingelheim
Baxter
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot